Latest News
Amid a sector rotation into small-caps, Morgan Stanley is bullish on growth names ahead of the Fed's expected policy shift. Here's a look at three ETFs that can benefit.
A Russell 2000 Bull Market Is Coming: 1 Unstoppable Vanguard ETF to Buy Hand Over Fist
Small-cap stocks are on fire in July, but the Russell 2000 is still in a technical bear market.
1 Historically Cheap Vanguard Index Fund to Buy Before It Soars 40%, According to a Wall Street Analyst
Tom Lee at Fundstrat Global Advisors believes cheap valuations and interest rate cuts will send the Russell 2000 much higher by the end of the summer.
Seeking small-cap equity exposure as Fed rate-cut expectations start to rise? Here are three leading ETFs for small-cap stock investors.
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.16%. Stock indexes Tuesday finished mixed. A rally in mega-cap tech stocks Tuesday boosted the...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.63%. Stock indexes today are mixed. A rally in mega-cap tech stocks is boosting the...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.53%. Stock indexes today are mixed. A rebound in Nvidia today from Monday’s sharp losses...
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. US stock indexes settled mixed on Tuesday, with the Dow Jones Industrials posting a...
Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024
Stocks that traded heavily or had substantial price changes on Tuesday: Insmed, Agios rise; DraftKings, Atlantica fall
The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.39%. US stock indexes today are mixed, with the Dow Jones Industrials posting a 2-1/2...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.07%. US stock indexes today are slightly lower, with the Dow Jones Industrials posting a...
We are looking for U.S.-listed equities that are attractive for trend-followers
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Why Shares of Insmed Are Soaring This Week
The biotech company announced positive top-line trial results and received upgrades from analysts.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Why Insmed Stock Is Soaring Today
Investors applauded the company's latest clinical results.
The Five Biotech Stocks Every Investor Should Know About
Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Publication for...
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours
With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical laboratory services is...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
-- ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $77.2 Million for the Second Quarter of 2023 Reflects Highest Quarter of Sales Since...
Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
—Brensocatib Reduced Risk of Exacerbations Irrespective of Disease Severity in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) in Phase 2 WILLOW...